tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
HRMY is currently covered by 8 analysts with an average price target of $44.94. This is a potential upside of $13.03 (15.38%) from yesterday's end of day stock price of $38.95.
Harmony Biosciences Holdings's activity chart (see below) currently has 158 price targets and 178 ratings on display. The stock rating distribution of HRMY is 83.33% BUY, 4.17% SELL and 12.5% HOLD.
Analysts average stock forecasts to be materialized ratio is 34.05% with an average time for these price targets to be met of 105.12 days.
Highest price target for HRMY is $62, Lowest price target is $28, average price target is $44.94.
Most recent stock forecast was given by DANIELLE BRILL from TRUIST on 05-Aug-2026. First documented stock forecast 11-Sep-2020.
Currently out of the existing stock ratings of HRMY, 20 are a BUY (83.33%), 1 are a SELL (4.17%), 3 are a HOLD (12.5%).
12/5/00 3 for 1
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 08-May-2026
$34
$-4.15 (-10.88%)
$29
Buy Since 22-Sep-2021
$50
$11.85 (31.06%)
$44
Buy Since 01-Sep-2022
$51
$12.85 (33.68%)
$46
Hold Since 30-Jun-2026
$36
$-2.15 (-5.64%)
$47
Buy Since 17-Dec-2024
$55
$19.53 (55.06%)
$55
What is HRMY (Harmony Biosciences Holdings) average time for price targets to be met?
Which analyst has the current highest performing score on HRMY (Harmony Biosciences Holdings) with a proven track record?
Which analyst has the most public recommendations on HRMY (Harmony Biosciences Holdings)?
Which analyst is the currently most bullish on HRMY (Harmony Biosciences Holdings)?
Which analyst is the currently most reserved on HRMY (Harmony Biosciences Holdings)?
